Abstract:BACKGROUND & AIMS:Levels of the Golgi protein 73 (GP73) increase during development of hepatocellular carcinoma (HCC); GP73 is a serum marker for HCC. However, little is known about the mechanisms or effects of GP73 during hepatic carcinogenesis.METHODS:GP73 was overexpressed from a retroviral vector in HepG2 cells, which were analyzed in proliferation and migration assays. Xenograft tumors were grown from these cells in nude mice. The effects of monoclonal antibodies against GP73 were studied in mice and cell lines. GP73(-/-), GP73(+/-), and GP73(+/+) mice were given injections of diethylnitrosamine to induce liver injury. Levels of GP73 were reduced in MHCC97H, HCCLM3, and HepG2.215 cell lines using small hairpin RNAs; xenograft tumors were grown in mice from MHCC97H-small hairpin GP73 or MHCC97H-vector cells. We used microarray analysis to compare expression patterns between GP73-knockdown and control MHCC97H cells. We studied the effects of the mechanistic target of rapamycin (mTOR) inhibitor rapamycin on GP73 expression in different cancer cell lines and on growth of tumors in mice. Levels of GP73 and activated mTOR were quantified in human HCC tissues.RESULTS:Xenograft tumors grown from HepG2 cells that expressed GP73 formed more rapidly and more metastases than control HepG2 cells in mice. A monoclonal antibody against GP73 reduced proliferation of HepG2 cells and growth of xenograft tumors in mice. GP73(-/-) mice had less liver damage after administration of diethylnitrosamine than GP73(+/-) or GP73(+/+) mice. In phosphatase and tensin homolog-null mouse embryonic fibroblasts with constitutively activated mTOR, GP73 was up-regulated compared with control mouse embryonic fibroblasts; this increase was reversed after incubation with rapamycin. Expression of GP73 also was reduced in HCC and other cancer cell lines incubated with rapamycin. mTORC1 appeared to regulate expression of GP73 in cell lines. Activated mTOR correlated with the level of GP73 in human HCC tissues. Injection of rapamycin slowed the growth of xenograft tumors from MHCC97H-vector cells, compared with MHCC97H-short hairpin GP73 cells.CONCLUSIONS:Increased expression of GP73 promotes proliferation and migration of HCC cell lines and growth of xenograft tumors in mice. mTORC1 regulates the expression of GP73, so GP73 up-regulation can be blocked with rapamycin. mTOR inhibitors or other reagents that reduce the level or activity of GP73 might be developed for the treatment of HCC.

Deletion of Golgi Protein 73 Delayed Hepatocyte Proliferation of Mouse in the Early Stages of Liver Regeneration.

Knockdown of Golgi Phosphoprotein 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Motility

Effect of Golgi Phosphoprotein 2 (GOLPH2/GP73) on Autophagy in Human Hepatocellular Carcinoma HepG2 Cells

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.

Suppression of Liver Regeneration and Hepatocyte Proliferation in Hepatocyte-Targeted Glypican 3 Transgenic Mice

Aberrant Expression of Golgi Protein 73 is Indicative of A Poor Outcome in Hepatocellular Carcinoma

Effect of Gp73 Silencing on Proliferation and Apoptosis in Hepatocellular Cancer

Advances on Golgi Glycoprotein 73 and Its Association with Diseases

Golgi Protein 73 Promotes Angiogenesis in Hepatocellular Carcinoma

Mtorc1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.

GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction

Investigation of the Role of Glypican 3 in Liver Regeneration and Hepatocyte Proliferation.

Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation

GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways

Knockdown of Golgi Phosphoprotein 73 Blocks the Trafficking of Matrix Metalloproteinase-2 in Hepatocellular Carcinoma Cells and Inhibits Cell Invasion

Serum Golgi Protein 73 is a Prognostic Biomarker of Liver Transplantation Patients.

GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity

Loss of Gsα impairs liver regeneration through a defect in the crosstalk between cAMP and growth factor signaling

Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion.

Endogenous Interleukin 18 Suppresses Liver Regeneration After Hepatectomy in Mice

Regulation of mice liver regeneration by early growth response-1 through the GGPPS/RAS/MAPK pathway.